The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.01093
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Apoptosis Rate and Transcriptional Response of Pancreatic Islets Exposed to the PPAR Gamma Agonist Pioglitazone

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

The PPAR Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Beyond Discovery Tools: The Evolution of Discovery at ECU Libraries

Against the Grain
2016English

Pioglitazone Modulates the Proliferation and Apoptosis of Vascular Smooth Muscle Cells via Peroxisome Proliferators-Activated Receptor-Gamma

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Translating Laboratory Discovery to the Clinic: From Nicotine and Mecamylamine to Tourette's, Depression, and Beyond

Physiology and Behavior
PhilosophyBehavioral NeuroscienceExperimentalCognitive Psychology
2012English

Being Human in Medicine: Beyond Hierarchy

International Journal of Whole Person Care
2015English

PPAR Gamma and Angiogenesis: Endothelial Cells Perspective

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2016English

From Genomic Drug Discovery to Tailor-Made Medicine

TRENDS IN THE SCIENCES
2001English

Discovery and Development of a New Insulin Sensitizing Agent, Pioglitazone.

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy